1. 9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trial. (14th September 2021) Authors: Gerhard‐Hartmann, Elena; Goergen, Helen; Bröckelmann, Paul J.; Mottok, Anja; Steinmüller, Tabea; Grund, Johanna; Zamò, Alberto; Ben‐Neriah, Susana; Sasse, Stephanie; Borchmann, Sven; Fuchs, Michael; Borchmann, Peter; Reinke, Sarah; Engert, Andreas; Veldman, Johanna; Diepstra, Arjan; Klapper, Wolf... Journal: British journal of haematology Issue: Volume 196:Number 1(2022) Page Start: 116 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AFM13 in patients with relapsed or refractory classical Hodgkin lymphoma: final results of an open-label, randomized, multicenter phase II trial. Issue 8 (3rd July 2022) Authors: Sasse, Stephanie; Bröckelmann, Paul Jan; Momotow, Jesko; Plütschow, Annette; Hüttmann, Andreas; Basara, Nadezda; Koenecke, Christian; Martin, Sonja; Bentz, Martin; Grosse-Thie, Christina; Thorspecken, Sven; de Wit, Maike; Kobe, Carsten; Dietlein, Markus; Tresckow, Bastian von; Fuchs, Michael; Bor... Journal: Leukemia & lymphoma Issue: Volume 63:Issue 8(2022) Page Start: 1871 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group. Issue 10 (October 2016) Authors: Kreissl, Stefanie; Mueller, Horst; Goergen, Helen; Mayer, Axel; Brillant, Corinne; Behringer, Karolin; Halbsguth, Teresa Veronika; Hitz, Felicitas; Soekler, Martin; Shonukan, Oluwatoyin; Rueffer, Jens Ulrich; Flechtner, Hans-Henning; Fuchs, Michael; Diehl, Volker; Engert, Andreas; Borchmann, Peter Journal: Lancet oncology Issue: Volume 17:Issue 10(2016:Oct.) Page Start: 1453 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Current and future immunotherapeutic approaches in Hodgkin lymphoma. Issue 9 (1st September 2016) Authors: Bröckelmann, Paul J.; Borchmann, Peter; Engert, Andreas Journal: Leukemia & lymphoma Issue: Volume 57:Issue 9(2016:Sep.) Page Start: 2014 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Defining a Hodgkin lymphoma population for novel therapeutics after relapse from autologous hematopoietic cell transplant. Issue 11 (November 2013) Authors: Arai, Sally; Fanale, Michelle; deVos, Sven; Engert, Andreas; Illidge, Tim; Borchmann, Peter; Younes, Anas; Morschhauser, Franck; McMillan, Alex; Horning, Sandra J. Journal: Leukemia & lymphoma Issue: Volume 54:Issue 11(2013:Nov.) Page Start: 2531 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase‐I trial. (28th December 2018) Authors: Böll, Boris; Plütschow, Annette; Bürkle, Carolin; Atta, Johannes; Pfreundschuh, Michael; Feuring‐Buske, Michaela; Vogelhuber, Martin; Sökler, Martin; Eichenauer, Dennis A.; Thielen, Indra; von Tresckow, Bastian; Fuchs, Michael; Engert, Andreas; Borchmann, Peter Journal: British journal of haematology Issue: Volume 185:Number 1(2019) Page Start: 42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial. Issue 10216 (21st December 2019) Authors: Poeschel, Viola; Held, Gerhard; Ziepert, Marita; Witzens-Harig, Mathias; Holte, Harald; Thurner, Lorenz; Borchmann, Peter; Viardot, Andreas; Soekler, Martin; Keller, Ulrich; Schmidt, Christian; Truemper, Lorenz; Mahlberg, Rolf; Marks, Reinhard; Hoeffkes, Heinz-Gert; Metzner, Bernd; Dierlamm, Judi... Journal: Lancet Issue: Volume 394:Issue 10216(2019) Page Start: 2271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Hematologic Rescue of CAR T-cell–mediated Prolonged Pancytopenia Using Autologous Peripheral Blood Hematopoietic Stem Cells in a Lymphoma Patient. Issue 3 (17th March 2021) Authors: Gödel, Philipp; Sieg, Noëlle; Heger, Jan-Michel; Kutsch, Nadine; Herling, Carmen; Bärmann, Ben-Niklas; Scheid, Christof; Borchmann, Peter; Holtick, Udo Journal: HemaSphere Issue: Volume 5:Issue 3(2021) Page Start: e545 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Histopathological growth patterns in patients with advanced nodular lymphocyte‐predominant Hodgkin lymphoma treated within the randomized HD18 study: a report from the German Hodgkin Study Group. (15th August 2021) Authors: Eichenauer, Dennis A.; Bühnen, Ina; Kreissl, Stefanie; Goergen, Helen; Fuchs, Michael; von Tresckow, Bastian; Rosenwald, Andreas; Klapper, Wolfram; Hansmann, Martin‐Leo; Möller, Peter; Bernd, Heinz‐Wolfram; Feller, Alfred C.; Engert, Andreas; Borchmann, Peter; Hartmann, Sylvia Journal: British journal of haematology Issue: Volume 196:Number 1(2022) Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. How I treat advanced Hodgkin lymphoma — a global view. (19th June 2020) Authors: Hokland, Peter; Shah, Mansi; David, Kevin; Evens, Andrew; Auer, Rebecca; Ledieu, Rifca; Kreissl, Stefanie; Bröckelmann, Paul J.; Borchmann, Peter; Korula, Anu; Mathews, Vikram; Owattanapanich, Weerapat; Trotman, Judith Journal: British journal of haematology Issue: Volume 190:Number 6(2020) Page Start: 837 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗